Literature DB >> 21210088

P2Y1 transient overexpression induced mineralization in spinal ligament cells derived from patients with ossification of the posterior longitudinal ligament of the cervical spine.

Sunao Tanaka1, Hitoshi Kudo, Toru Asari, Atsushi Ono, Shigeru Motomura, Satoshi Toh, Ken-Ichi Furukawa.   

Abstract

Ossification of the posterior longitudinal ligament of the spine (OPLL) is characterized by ectopic bone formation in the spinal ligaments. We previously reported that P2 purinoceptor Y1 (P2Y1) expression is elevated in the spinal ligament cells of OPLL patients, but the role of P2Y1 in the spinal ligament calcification process is unknown. To verify the hypothesis that P2Y1 expression causes ossification of the spinal ligaments, we forced expression of P2Y1 in spinal ligament cells obtained from OPLL and non-OPLL patients using a cytomegaloviral vector. The expression of mRNA and protein was investigated by quantitative real-time polymerase chain reaction and immunofluorescence staining, respectively. After transfection, bone morphogenetic protein-2 (BMP-2) and Sox9 mRNA expression was significantly increased in spinal ligament cells derived from OPLL patients (4.36- and 6.44-fold, respectively) compared with cells from non-OPLL patients (0.57- and 3.64-fold, respectively) 2 days after P2Y1 transient transfection. Furthermore, a statistically significant correlation was observed between BMP-2 and P2Y1 mRNA expression levels in cells obtained from OPLL patients but not from non-OPLL patients. Immunofluorescence analysis showed that BMP-2 and P2Y1 expression was increased in OPLL patients only, while Sox9 expression was increased in OPLL and non-OPLL patients. MRS2279, a selective P2Y1 antagonist, blocked the upregulation of Sox9 and BMP-2 after forced expression of P2Y1. Furthermore, 4 days after transient transfection of P2Y1, mineralization was observed only in spinal ligament cells from OPLL patients. These results suggest that P2Y1 expression plays an important role in ectopic bone formation in the spinal ligaments of OPLL patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210088     DOI: 10.1007/s00223-010-9456-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  The regulation of Sox2 and Sox9 stimulated by ATP in spinal cord astrocytes.

Authors:  Maosheng Xia; Yue Zhu
Journal:  J Mol Neurosci       Date:  2014-08-13       Impact factor: 3.444

Review 4.  Signaling of the Purinergic System in the Joint.

Authors:  Carmen Corciulo; Bruce N Cronstein
Journal:  Front Pharmacol       Date:  2020-01-24       Impact factor: 5.810

Review 5.  Extracellular Nucleotides Regulate Arterial Calcification by Activating Both Independent and Dependent Purinergic Receptor Signaling Pathways.

Authors:  Britt Opdebeeck; Isabel R Orriss; Ellen Neven; Patrick C D'Haese; Anja Verhulst
Journal:  Int J Mol Sci       Date:  2020-10-15       Impact factor: 5.923

6.  Genetic Odyssey to Ossification of the Posterior Longitudinal Ligament in the Cervical Spine: A Systematic Review.

Authors:  Young Il Won; Chang-Hyun Lee; Woon Tak Yuh; Shin Won Kwon; Chi Heon Kim; Chun Kee Chung
Journal:  Neurospine       Date:  2022-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.